CardiaTec
CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.
2
Funding Rounds
$8.2m
Money raised
Overview
CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.
-
Website:
- Business model: B2B
- Headquarters: Cambridge, Cambridgeshire
- Social accounts:
Funding
Funding series
Funding Series Analysis
The company CardiaTec has raised a total of $8.2m in funding over 2 rounds.
Key Insights:
- CardiaTec Seed Round, September 2024: $6.5m
- CardiaTec Biosciences July 2022 Pre-Seed Funding Round: $1.7m
CardiaTec Seed Round, September 2024
$6.5m
CardiaTec Biosciences July 2022 Pre-Seed Funding Round
$1.7m
Industries
CardiaTec is active in the following industries: